1h Free Analyst Time
The audiological devices market is forecasted to grow by USD 5.44 billion during 2023-2028, accelerating at a CAGR of 8.9% during the forecast period. The report on the audiological devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of hearing loss, supportive healthcare policies, government initiatives, and subsidies for hearing aids, and increase in noise-induced hearing loss due to rising noise pollution levels.
The audiological devices market is segmented as below:
By End-user
- Adults
- Pediatrics
By Product
- Hearing aids
- Cochlear implants
- BAHA/BAHS
- Diagnostic devices
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the audiological devices market covers the following areas:
- Audiological devices market sizing
- Audiological devices market forecast
- Audiological devices market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Additional Value/Volume Data
7 Five Forces Analysis
8 Market Segmentation by End-user
9 Market Segmentation by Product
10 Customer Landscape
11 Geographic Landscape
12 Drivers, Challenges, and Opportunity/Restraints
13 Competitive Landscape
14 Competitive Analysis
15 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global audiological devices market: Amplifon SpA, Audina Hearing Instruments Inc., Bernafon AG, Cochlear Ltd., Demant AS, Earlens Corp., Envoy Medical Corp., GN Store Nord AS, Inventis s.r.l., MAICO Diagnostics GmbH, MED EL Medical Electronics., MedRx Inc., Medtronic, Oticon, RION Co. Ltd., Siemens Healthineers AG, Sonova AG, Starkey Laboratories Inc., WS Audiology AS, and ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing focus of vendors on new audiological product development."
According to the report, one of the major drivers for this market is the increasing prevalence of hearing loss.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Amplifon SpA
- Audina Hearing Instruments Inc.
- Bernafon AG
- Cochlear Ltd.
- Demant AS
- Earlens Corp.
- Envoy Medical Corp.
- GN Store Nord AS
- Inventis s.r.l.
- MAICO Diagnostics GmbH
- MED EL Medical Electronics.
- MedRx Inc.
- Medtronic
- Oticon
- RION Co. Ltd.
- Siemens Healthineers AG
- Sonova AG
- Starkey Laboratories Inc.
- WS Audiology AS
- ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD.
